The Influence of Pre-Analytical Factors on the Analysis of Circulating MicroRNA

Hiromichi Shiotsu, Kazuhiro Okada, Tatsuki Shibuta, Yuki Kobayashi, Saki Shirahama, Chieri Kuroki, Saori Ueda, Masanori Ohkuma, Katsuyoshi Ikeda, Yukio Ando, Hirotaka Matsui, Yuzo Kayamori, Tsukuru Umemura

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

BACKGROUND: MicroRNAs (miRNA) are expected as useful biomarkers for various diseases. We studied the pre-analytical factors causing variation in the analysis of miRNA. MATERIAL AND METHODS: Blood samples were collected from 25 healthy subjects. Plasma and serum were obtained from the same samples. The levels of miR-451, -16, -126, and -223 were analyzed using RT-qPCR. Cel-miR-39 was added as a spiked-in control in each sample. RESULTS: With the exception of miR-451, the levels of the miRNAs in plasma were higher than in serum. After high-speed centrifugation, the levels of miRNAs were almost equal between plasma and serum except for miR-451. Membrane filtration with 0.45 µm pore size reduced the levels of plasma miRNAs. The coagulation accelerators for serum processing did not affect the analysis of miRNA. The use of fraction containing particles of > 0.45 µm in size showed the inhibitory effect on the analysis of plasma miR-451. The RNase inhibitor was effective for protecting against the degradation of miRNAs. CONCLUSION: Plasma contains factors modifying miRNA profiles. The immediate processing of plasma with membrane filtration and RNase inhibitor may be a relevant method for achieving the stable analysis of miRNA.

Original languageEnglish
Pages (from-to)195-203
Number of pages9
JournalMicroRNA (Shariqah, United Arab Emirates)
Volume7
Issue number3
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

MicroRNAs
Statistical Factor Analysis
Ribonucleases
Serum
Centrifugation
Healthy Volunteers
Biomarkers
Cell Membrane
Membranes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

The Influence of Pre-Analytical Factors on the Analysis of Circulating MicroRNA. / Shiotsu, Hiromichi; Okada, Kazuhiro; Shibuta, Tatsuki; Kobayashi, Yuki; Shirahama, Saki; Kuroki, Chieri; Ueda, Saori; Ohkuma, Masanori; Ikeda, Katsuyoshi; Ando, Yukio; Matsui, Hirotaka; Kayamori, Yuzo; Umemura, Tsukuru.

In: MicroRNA (Shariqah, United Arab Emirates), Vol. 7, No. 3, 01.01.2018, p. 195-203.

Research output: Contribution to journalArticle

Shiotsu, H, Okada, K, Shibuta, T, Kobayashi, Y, Shirahama, S, Kuroki, C, Ueda, S, Ohkuma, M, Ikeda, K, Ando, Y, Matsui, H, Kayamori, Y & Umemura, T 2018, 'The Influence of Pre-Analytical Factors on the Analysis of Circulating MicroRNA', MicroRNA (Shariqah, United Arab Emirates), vol. 7, no. 3, pp. 195-203. https://doi.org/10.2174/2211536607666180709143335
Shiotsu, Hiromichi ; Okada, Kazuhiro ; Shibuta, Tatsuki ; Kobayashi, Yuki ; Shirahama, Saki ; Kuroki, Chieri ; Ueda, Saori ; Ohkuma, Masanori ; Ikeda, Katsuyoshi ; Ando, Yukio ; Matsui, Hirotaka ; Kayamori, Yuzo ; Umemura, Tsukuru. / The Influence of Pre-Analytical Factors on the Analysis of Circulating MicroRNA. In: MicroRNA (Shariqah, United Arab Emirates). 2018 ; Vol. 7, No. 3. pp. 195-203.
@article{63840eee61784ef1ba2f1f32f640e134,
title = "The Influence of Pre-Analytical Factors on the Analysis of Circulating MicroRNA",
abstract = "BACKGROUND: MicroRNAs (miRNA) are expected as useful biomarkers for various diseases. We studied the pre-analytical factors causing variation in the analysis of miRNA. MATERIAL AND METHODS: Blood samples were collected from 25 healthy subjects. Plasma and serum were obtained from the same samples. The levels of miR-451, -16, -126, and -223 were analyzed using RT-qPCR. Cel-miR-39 was added as a spiked-in control in each sample. RESULTS: With the exception of miR-451, the levels of the miRNAs in plasma were higher than in serum. After high-speed centrifugation, the levels of miRNAs were almost equal between plasma and serum except for miR-451. Membrane filtration with 0.45 µm pore size reduced the levels of plasma miRNAs. The coagulation accelerators for serum processing did not affect the analysis of miRNA. The use of fraction containing particles of > 0.45 µm in size showed the inhibitory effect on the analysis of plasma miR-451. The RNase inhibitor was effective for protecting against the degradation of miRNAs. CONCLUSION: Plasma contains factors modifying miRNA profiles. The immediate processing of plasma with membrane filtration and RNase inhibitor may be a relevant method for achieving the stable analysis of miRNA.",
author = "Hiromichi Shiotsu and Kazuhiro Okada and Tatsuki Shibuta and Yuki Kobayashi and Saki Shirahama and Chieri Kuroki and Saori Ueda and Masanori Ohkuma and Katsuyoshi Ikeda and Yukio Ando and Hirotaka Matsui and Yuzo Kayamori and Tsukuru Umemura",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/2211536607666180709143335",
language = "English",
volume = "7",
pages = "195--203",
journal = "MicroRNA (Shariqah, United Arab Emirates)",
issn = "2211-5366",
publisher = "Bentham Science Publishers",
number = "3",

}

TY - JOUR

T1 - The Influence of Pre-Analytical Factors on the Analysis of Circulating MicroRNA

AU - Shiotsu, Hiromichi

AU - Okada, Kazuhiro

AU - Shibuta, Tatsuki

AU - Kobayashi, Yuki

AU - Shirahama, Saki

AU - Kuroki, Chieri

AU - Ueda, Saori

AU - Ohkuma, Masanori

AU - Ikeda, Katsuyoshi

AU - Ando, Yukio

AU - Matsui, Hirotaka

AU - Kayamori, Yuzo

AU - Umemura, Tsukuru

PY - 2018/1/1

Y1 - 2018/1/1

N2 - BACKGROUND: MicroRNAs (miRNA) are expected as useful biomarkers for various diseases. We studied the pre-analytical factors causing variation in the analysis of miRNA. MATERIAL AND METHODS: Blood samples were collected from 25 healthy subjects. Plasma and serum were obtained from the same samples. The levels of miR-451, -16, -126, and -223 were analyzed using RT-qPCR. Cel-miR-39 was added as a spiked-in control in each sample. RESULTS: With the exception of miR-451, the levels of the miRNAs in plasma were higher than in serum. After high-speed centrifugation, the levels of miRNAs were almost equal between plasma and serum except for miR-451. Membrane filtration with 0.45 µm pore size reduced the levels of plasma miRNAs. The coagulation accelerators for serum processing did not affect the analysis of miRNA. The use of fraction containing particles of > 0.45 µm in size showed the inhibitory effect on the analysis of plasma miR-451. The RNase inhibitor was effective for protecting against the degradation of miRNAs. CONCLUSION: Plasma contains factors modifying miRNA profiles. The immediate processing of plasma with membrane filtration and RNase inhibitor may be a relevant method for achieving the stable analysis of miRNA.

AB - BACKGROUND: MicroRNAs (miRNA) are expected as useful biomarkers for various diseases. We studied the pre-analytical factors causing variation in the analysis of miRNA. MATERIAL AND METHODS: Blood samples were collected from 25 healthy subjects. Plasma and serum were obtained from the same samples. The levels of miR-451, -16, -126, and -223 were analyzed using RT-qPCR. Cel-miR-39 was added as a spiked-in control in each sample. RESULTS: With the exception of miR-451, the levels of the miRNAs in plasma were higher than in serum. After high-speed centrifugation, the levels of miRNAs were almost equal between plasma and serum except for miR-451. Membrane filtration with 0.45 µm pore size reduced the levels of plasma miRNAs. The coagulation accelerators for serum processing did not affect the analysis of miRNA. The use of fraction containing particles of > 0.45 µm in size showed the inhibitory effect on the analysis of plasma miR-451. The RNase inhibitor was effective for protecting against the degradation of miRNAs. CONCLUSION: Plasma contains factors modifying miRNA profiles. The immediate processing of plasma with membrane filtration and RNase inhibitor may be a relevant method for achieving the stable analysis of miRNA.

UR - http://www.scopus.com/inward/record.url?scp=85058446498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058446498&partnerID=8YFLogxK

U2 - 10.2174/2211536607666180709143335

DO - 10.2174/2211536607666180709143335

M3 - Article

VL - 7

SP - 195

EP - 203

JO - MicroRNA (Shariqah, United Arab Emirates)

JF - MicroRNA (Shariqah, United Arab Emirates)

SN - 2211-5366

IS - 3

ER -